Myriad Genetics (MYGN) Acquisitions (2011 - 2018)

Myriad Genetics (MYGN) has 4 years of Acquisitions data on file, last reported at -$1.1 million in Q4 2018.

• Acquisitions for Q4 2018 came in at -$1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was -$1.1 million (changed N/A YoY), and the FY2022 annual result was $57.2 million, changed N/A from the prior year.
• Acquisitions eased to -$1.1 million in Q4 2018 per MYGN's latest filing, from $279.6 million in the prior quarter.
• Over five years, Acquisitions peaked at $279.6 million in Q3 2018 and troughed at -$1.1 million in Q4 2018.
• A 3-year average of $98.9 million and a median of $3.1 million in 2016 frame the typical range for Acquisitions.